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1. Introduction 
Since  the introduction in 1987 by Phillip Mouret of the first laparoscopic cholecystectomy (LC) in 
the human and since the publishing  in 1989 of the first experience with the laparoscopic technique  
by Périssat et al 1, this  technique rapidly became the standard of care for the management of 
symptomatic cholelithiasis. The introduction of LC caused a revolutionary development of the 
laparoscopic technique within general surgery, and several laparoscopic procedures are now ‘the 
gold standard’ within this field, e.g. laparoscopic reflux surgery2, appendectomy3, adrenalectomy4, 
some forms of obesity surgery 5, and within the treatment of subgroups of inguinal hernia6. The 
indications for laparoscopic resection of potentially curable colo-rectal cancer have not been 
defined yet and are awaiting the the results of the ongoing, randomized trials to address the overall 
important issues of cancer recurrence and survival. However, so far the primary results suggest 
that laparoscopic surgery will also get an important role within oncologic surgery7.  
The prerequisite for laparoscopic surgery is a working cavity. Positive pressure 
CO2 -pneumoperitoneum (CO2-PP) and positional changes of the patients are the general 
techniques by which to expose the intraperitoneal organs. Carbonic dioxide (CO2) is the preferred 
gas, because it is inexpensive, highly soluble, and chemically stable. In addition, it is a normal 
product of human metabolism and suppresses combustion. With respect to CO2-PP  there is  
concern, however, that it may affect the cardiovascular and pulmonary functions. CO2 is absorbed 
from the peritoneal cavity into the circulation, where it may result in hypercarbia, acid-base 
disturbances and affect the systemic response and the plasma cascade systems. In addition to the 
effect of positive pressure pneumoperitoneum and the absorbed CO2 , the positional changes of the 
patients from Trendelenburg to reverse Trendelenburg positions may add to the pathophysiological 
effects, e.g. stimulate the coagulation system. 
As the numbers of laparoscopic procedures are rising and now also offered to 
patients with co-morbidity, it is mandatory to be aware of the specific, intraoperative, 
pathophysiological effects that are related to laparoscopic surgery, when using positive  pressure 
CO2-PP and to evaluate alternative, minimally invasive methods.  
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2. Background 
2.1 Clinical background 
It is a common belief that minimally invasive surgery has important effects on the clinical 
outcome. However, controlled evaluation of the laparoscopic technique has been scarce, and  
relatively few prospective, randomized trials have been performed to define the indications for the 
laparoscopic approach and to confirm its benefits, when compared with standard operations of 
open surgery 3,7-32. Table 1 summarizes the trials regarding intervention, number, perioperative 
outcome, follow-up, and recommendations within various laparoscopic procedures. The 
randomized studies suggest that the surgical trauma  represents an important factor in determining 
the outcome. Other factors - e.g. CO2-PP - may contribute to the postoperative morbidity , as 
stated by Kehlet 33,34. Five studies randomly comparing CO2-PP with the gasless 
technique10,13,14,17,35 showed reduced nausea 10,14, vomitting 10,14 and shoulder pain 10,13,14 in the 
gasless group. However, in a small study, including 17 patients, randomly assigned to CO2-PP or 
gasless laparoscopic colon resection, less pain, but more fatigue was found in the CO2-PP group 35. 
Further studies are needed to investigate the effects of CO2-PP regarding perioperative course and 
convalescence.   
2.2 Coagulation and fibrinolysis 
Although conventional, laparoscopic cholecystectomy is regarded as a minimally invasive 
procedure, avoiding much of the tissue injury associated with traditional laparotomy, the 
perioperative changes in plasma levels of these markers do not seem substantially different from 
those found in open cholecystectomy 36-39. This has been confirmed in randomized, controlled 
trials comparing patients undergoing laparoscopic vs. open colon resection 40, and laparoscopic 
gastric bypass vs. open gastric bypass 41. The clinical consequences of these changes regarding e.g. 
thromboembolic complications are not known, nor are the pathophysiological mechanisms 
releasing the coagulation system. PP and reverse Trendelenburg position may lead to venous stasis 
in the legs 42,43. In addition, the venous stasis during PP could affect the endothelium and induce 
changes in coagulation and fibrinolysis. These factors could mask true differences between 
laparoscopic and open surgery44,45.  Based on these observations it may be hypothesized that CO2-
PP may trigger the coagulation and fibrinolytic systems. 
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2.3 Endocrine, metabolic, and immune responses 
Major surgical injury is followed by changes in the metabolic, endocrine, and inflammatory   
responses. Together with the increased demands on organ functions this constitutes the stress 
response 33,46. The response may lead to postoperative hypermetabolism, catabolism, increased  
demands on body organs and changes in host defense mechanism 46,47. Within open surgery the 
responses apparent are proportional to the degree of injury 48 and support the hypothesis that 
surgical stress response may have harmful effects on the postoperative course and be correlated 
with clinical development of complications 33,49. Therefore, it is important to investigate the 
pathophysiological role of the various components of the surgical stress response and to determine 
if modifications of such responses may improve surgical outcome. In 1998 Kehlet 47 when 
reviewing the literature concluded that laparoscopic surgery as compared with that of open has no 
important effects on the endocrine, metabolic response, but may result in a reduced, inflammatory 
response. Additional randomized studies published since have shown a tendency towards a 
reduced, metabolic, endocrine, and inflammatory response, when using C02-PP, as compared with 
open surgery 9,35,50-59. Table 2 summarizes the results of the randomized, controlled and 
observational trials performed  since 1998. 
 It has been suggested that the cellular acidification induced by CO2-PP may 
contribute to the blunting of the inflammatory response during laparoscopic surgery 60. Apparently 
Helium, which does not result in acidosis,  is more capable than CO2-PP of preserving cell-
mediated, intraperitoneat immunity, causing less pronounced cytocin response61, However, Helium 
pneumoperitoneum  does not appear to protect against increase in stress hormones62. Few studies 
have investigated the systemic response in patients undergoing gasless laparoscopy and compared 
it with that of  CO2-PP technique 35,50,52,59. Two studies demonstrated reduced hormonal response 
in the gasless group 52,59, and two studies did not find any difference 35,50,59. As CO2-PP results in 
absorption of  CO2, resulting in acidosis, and as the positive, intraabdominal pressure has systemic 
effects, it is relevant to perform further studies comparing the systemic response and outcome in 
patients undergoing CO2-PP or gasless laparoscopy  
2.4 Haemodynamics 
Alterations in haemodynamics depend on the interaction of several patient and procedure related 
factors: concomitant disease, intraabdominal pressure, patient position, CO2 absorption, 
neurohumeral response, and the nature and duration of the procedure. In addition, the intravascular 
volume, the preexisting cardiovascular status of the patients, and the anaesthetic agents used can 
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influence the cardiovascular response during CO2-PP. In the light of this complexity it is not 
surprising that the published data are inconsistently reported (Tabel 3). Most studies report an  
increased systemic resistance, increased mean arterial pressure, and little change in heart rate. 
Similarly,  the results of studies investigating the effect of CO2-PP on heart performance are 
conflicting, some showing a decrease, few an increase and many no change in cardiac output (CO) 
or cardiac index (CI) during PP. To evaluate the influence of CO2-PP, a randomized design 
involving the same surgical and anaesthetic procedure with and without CO2-PP seems logical. 
When we planned our study, six studies had already been published comparing CO2-PP with 
gasless technique (Table 4) 10,63-67, without, however, using transoesophageal echocardiography 
(TOE) for the monitoring of heart function. At that time it was stated that further studies using 
TOE were needed to examine more closely the intracardiac consequences of CO2-PP and to 
compare mechanical technique with CO2-PP 68. 
2.5 Intraoperative lung function 
CO2-PP in various ways affects the intraoperative lung function: the lung mechanics, gas exchange 
and CO2 homeostasis. During CO2-PP the airway pressure is increased 50,69,70 and the diaphragma 
cephalicly displaced. Additionally, the intrathoracic pressure increases, the abdominal part of the 
chest wall stiffens and the expansion of the lungs is restricted, reducing the functional, residual 
capacity 71 and compliance 72.  The combination of posture and positive intraabdominal pressure 
may affect the respiratory mechanism during surgery 73,74. Further, CO2-PP may impair gas 
exchange by mechanical compression of basal lung regions causing atelectasis and secondary, 
uneven ventilation-perfusion. However, only few studies have shown significant shunting with 
increased venous admixture during CO2-PP 73,75,76, and most authors have failed to show any 
change in oxygenation during CO2-PP.  CO2 is absorbed from the peritoneum into the circulation. 
If the increased CO2 load cannot be eliminated by the lungs, retension in the body, hypercarbia and 
acidosis may follow 77. Few have investigated gas exchange keeping the ventilation constant 
during CO2-PP 78-80 and compared it with the gasless technique and during changes in positioning 
as well81,82.    
 
 2.6 Hypotheses and aims 
The effects of positive pressure pneumoperitoneum, CO2 absorption, and position of the patients  
may be considered important factors for the interpretation of the differences in clinical and 
physiological responses between open,  conventional laparoscopy using CO2-PP and gasless 
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techniques. It can be hypothesized that CO2-PP may affect: 
• The outcome after laparoscopic surgery  by increasing visceral and shoulder pain, 
nausea, and vomitting, resulting in prolonged convalescence compared with that of 
gasless laparoscopy. 
• The coagulation and fibrinolytic system as a consequence of venous stasis in the legs.    
• The inflammatory responses which may be caused by hypercarbia and acidosis 
during insufflation of CO2 . 
• The haemodynamic and heart performance caused by affection of preload, afterload, 
and contractility during CO2-PP. 
• The perioperative lung  mechanism, CO2 –homeostasis with hypercabnia, acidosis 
and accumulation of  CO2 .  
In paper I the feasibility of gasless LC is investigated and the clincal course regarding operative 
time, postoperative pain, hospital stay and convalescence is compared with that of CO2-PP LC.  
Papers II and III compare  the perioperative coagulation, fibrinolytic and surgical stress responses 
during CO2-PP and gasless LC. Paper IV compares the effect of CO2-PP and the positional 
changes with that of gasless LC  on the haemodynamics and cardiac function as determined by 
TOE. In paper V the perioperative lung function, oxygenation, CO2 homeostasis, and 
accumulation of CO2  is investigated. 
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3. Methodological considerations 
3.1 Mechanical abdominal wall  lift (AWL) 
In laparoscopic surgery AWL is an alternative gasless technique to CO2-PP for exposure of  the 
operative field. Most AWL systems consist of an anchoring device, inserted either into the 
subcutaneous layer of the the anterior abdominal wall or into the the peritoneal cavity, and a 
traction device fixed to the operating table. Depending on which device used, a tentlike cavity is 
created that often gives a small, intraabdominal working space. In this study we used the 
Laparotensor® (Lucini, Milan, Italy) with a curved subcutaneous anchoring system, theoretically 
having the advantages of avoiding damage to the intraabdominal organs, pressure trauma to the 
parietal peritoneum and creating a more domelike working cavity83. Generally,  AWL systems are  
connected with a reduced working space compared with that of CO2-PP, which make them  
particularly unsuitable for patients with high intraperitoneal fat content 83, for which reason 
patients with a body mass index over 30 were excluded from the study. 
3.2 Design 
The surgical techniques using AWL laparoscopy or conventional CO2-PP are comparable, which 
forms the basis for comparison of different clinical and physiological factors in patients 
undergoing laparoscopy with and without CO2-PP.  As several individual and procedure related 
factors may interact in the performing of laparoscopic surgery, we found the randomized, 
controlled trial comparing patients undergoing laparoscopy with and without CO2-PP to be most 
capable of evaluating the effect of CO2-PP. Experience, however, with the technique was essential  
for the conducting  of the trial, for which reason a pilot study  was performed. In order to minimize 
variation between the groups, a welldefined patient group was selected, and the anaesthesia, 
operative procedure, and postoperative treatment standardized. Patients and data collectors were 
blinded.  
3.3 Sample size 
The sample size was calculated under the following assumptions: expected difference in mean of  
10 procent, expected standard deviation 10 per cent, α = 0.05, power =0.90. A sample size of 46 
patients was sufficient to detect these differences. The operations were carried out once a week, 
except on holidays etc. Data was collected from 1 December 1998 to 1 October 1999. The patients 
were recruited from a waiting list, except for the inclusion and exclusion criteria, no selection bias 
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was made. A total number of 54 patients were included. The five studies are based on the same 
material. 
3.4 The endocrine, metabolic, and inflammatory responses 
The stress response may be summarized as follows: 
 
Effects  General response   Local response   
 Endocrine metabolic Immune   Neural    Humoral   
  ↑ 
 Catabolic acting 
hormones:    
Catecholamines        
Glucagon 
Cortisol 
 
 
 Interleukin-1 Interleukin-6 
Tumour necrosis factor 
Prostaglandin E2s  CRP 
plasmaconcentration 
Oxygen free radical release 
CRP-synthesis 
Peripheral neural 
stimulation 
 Complement 
system 
Arachnoid 
acid system 
Coagulation 
Fibrinolysis 
Histamine 
Serotonin 
cytokins  
   ↓ 
Anabolic acting 
hormones: Growth 
hormone 
Insulin 
 
 Delayed -type 
hypersensitivity response T 
cell-dependent antibody 
response Interleukin-2 
production Interleukin-2  
expression Interferon -γ 
production NK cell activity 
Neutrophil chemotaxies 
Phagocytocis 
  
  Outcome    
 Increased organ 
demands, catabolism, 
immunosuppression, 
organ dysfunction      
hyperglycaemia 
 Increased infectious 
complications and possible 
cancer recurrence7 
 Initiation of the 
stress response 
by transmitting 
the pain response 
to central 
nervosystem 
stimulating the 
adrenocortical 
response. 
Postoperative 
pain 
hypersensitivity 
 Facilitation 
of afferent 
neural stimuli. 
Coagulation 
Fibrinolysis  
Activation of 
kinins and 
complement 
system 
 
The effects on the intraoperative and postoperative, endocrine, metabolic responses were assessed 
by measuring the serum insulin (s-insulin), serum glucose (s-glucose) and serum cortisol (s-
cortisol). The inflammatory response was assessed by measuring serum C-reactive protein (CRP). 
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3.5 Coagulation and fibrinolysis 
The aim of this study was to detect activation of coagulation and fibrinolysis in vivo. Traditional 
assays are not well suited for this purpose, as they measure either plasma levels of clotting factors 
or the velocity of in vitro clotting or fibrinolysis (i.e. processes taking place in the laboratory). 
Instead, we used commercially available immunoassays for products generated by activation of 
coagulation or fibrinolysis. Prothrombin fragment 1+2 (F1+2) is a short-lived peptide released 
when prothrombin is converted into thrombin. Soluble fibrin is the soluble precursor of clots or 
thrombi, which form by aggregation of soluble fibrin and subsequent cross-linking. Lysis of such 
clots by plasmin releases cross-linked fibrin degradation products that may be identified by their 
neoantigen D-dimer (DD). Key steps in coagulation and fibrinolysis (i.e. thrombin generation, 
fibrin generation, and fibrinolysis) may thus be monitored by measurement of these markers  
 
 
 
Figure 1. Markers of coagulation and fibrinolysis shown in the double boxes  
 3.6 Heart performance   
Transoesophageal echocardiography (TOE) can be used to monitor cardiac left ventricular 
function throughout surgical procedures. It is a safe procedure, rendering high-quality  two-
dimension images and dobbler information.  There are, however, some technical difficulties, e.g. 
poor transmission of ultrasound through air-containing structures. In study IV, TOE was 
performed using a 5  Mhz 2 element annular monoplane probe. TOE included the short axis view 
at the mid papillary level, mitral annulus diameter in diastole and mitral flow curves at the mitral 
annular level. Measuring the short axis dimensions may be difficult, as the heart may change its 
relation to the transducer during insufflation and positional changes of the patient in addition to 
poor transmission caused by the CO2-PP. Especially in the reverse Trendelenburg position we 
noticed this problem. In half of the patients we were not able to obtain reliable short axis view. 
The left ventricular end diastolic diameter (LVEDD) was measured at mid papillary level and used 
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as an estimate of the left ventricular filling (preload). Left ventricular end systolic diameter 
(LVESD) was measured  at mid papillary level and used as an estimate of the systolic volume. The 
fractional shortening (FS) of the left ventricle of the heart was calculated ((LVEDD-
LVESD)/LVEDD) and used as an estimate of the left ventricular performance integrating the three 
determinants. An echocardiographically determined left ventricular end systolic and diastolic 
dimension can be used as a surrogate for left ventricular volume in the left ventricular pressure-
volume relation84.  
Cardiac output (CO) was calculated by multiplying the time velocity integral of the mitral flow 
(TVI) with cross sectional area of the mitral ostium (A) and the heart rate (HR): CO ( l /min ) = 
TVI .  A . HR . Calculations like these are, however, problematic, the greatest limitation being 
calculation of the sectional area. Thus, we were unable to calculate CO in 20-25% of our 
measurements. In addition, the diameter measured must be squared in the calculation of blood 
flow any errors would also be squared. Terai et al 85have shown, however, a close correlation (r = 
0.97) of CO calculated from TOE with CO, determined by the thermodilution technique. 
Furthermore, as the same method was used to evaluate the heart performance, changes between 
and within the groups may reflect true differences.  
3.7 Statistics  
In papers I, II, and III the non-parametric Mann-Whitney test was used to compare two groups. 
Fischer’s exact test was applied in case the frequency was less than five. Friedman’s analysis was 
used to detect changes with time within each group. The data are expressed as median and range. 
P-values of < 0.05 were considered significant.  
In paper IV analysis of variance (ANOVA) statistics was used to compare 
differences between and within more than two groups. Data was tested for normality. Three-way 
ANOVA was used to consider the effect of which method used during LC: CO2-PP or wall 
traction (factor 1), the position: supine, Trendelenburg, or reverse Trendelenburg (factor 2) and the 
time during operation (factor 3). Missing data was treated by using a general, linear model. A P 
value less than 0.05 was considered significant. To isolate the group or groups that differed from 
the others, Student-Newman-Keuls Method for pairwise multiple comparison was used. Two-way 
ANOVA was used to consider the effect of positional changes (factor 1) and the phases (factor 2) 
within the groups,. P value less than 0.05 was considered significant. Patient data were included in 
the analysis, until  time of conversion. Results are reported as mean ± SD. Statistical analysis was 
performed using the Jandel Sigmastat version 2.0 statistical package (SPSS Science   Chicago, 
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USA).  
In paper V we simplified the analysis by pooling data into two groups, CO2-PP 
group and gasless group. Data was tested for normality and the two groups compared using two-
tailed version of Student’s t test. Changes within one group were tested using One-way ANOVA. 
Multiple pairwise comparison was made with Student-Newman-Keuls Method metod, with the 
overall alpha level set at 0.05.  
  15
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5. General discussion 
5.1 Clinical outcome 
Pain is a common complaint after laparoscopic surgery. Many hypotheses have been put forward 
in the attempt to explain the aetiology of postlaparoscopic pain, which may be classified into three 
groups: visceral, incisional, and shoulder pain86,87. Traction of the triangular ligament, 
overstretching of the diaphragmatic muscle fibers due to a high rate of insufflation88, hypothermia 
caused by the gas used ,  direct peritoneal irritation by CO2 and /or the acidosis caused by 
hypercarbia89, and residual CO2 90 are some of the hypotheses. The multifactorial nature of 
postoperative pain, and the great inter-individual variation in early postoperative pain 87 may 
explain the contradictory results of the published data 91. If CO2-PP per se is an important factor, it 
may be expected that gasless laparoscopy result in reduced visceral and shoulder pain. Three 
randomized, controlled trials have been performed, comparing gasless with CO2-PP technique as 
regards  postoperative pain10,14,17. In neither of these studies local anaesthesia was administered. 
Two of the studies showed reduced shoulder pain 10,14 and one study increased shoulder pain, but 
no difference was found in visceral pain score 17. We did not register  any shoulder pain in patients 
operated by the gasless technique and only little in the CO2-PP group four hours postoperatively 
(I). Wound pain, dominant 8 to 24 hours postoperatively, was less pronounced than visceral pain 
(I), which is contrary to the findings by Bisgaard et al 86, who showed that  incisional pain 
dominated over shoulder and visceral pain, irrespective of administration of intraperitoneal, local 
anaesthesia. However, we did not find any significant differences in pain score, nor in morphine 
consumption at rest or during mobilization within or between the groups during hospital stay (I). 
One possible explanation could be that  local anaesthetics (bupivacaine 0.5 %) was administered in 
the port sites and subdiaphragmatically after removal of the gallblader, although the results of  
randomized, controlled trials, regarding intraperitoneal installation of  local anaesthetics are 
conflicting 91.  
An important parameter for the evaluation of the advantages of minimally 
invasive surgery is duration of convalescence or sick leave. It has been shown that improved 
patient information may reduce convalescence 92.We did not recommend a specific period of 
postoperative convalescence, but asked the patients to score activity, pain, nausea, and fatique for 
14 days. The two groups of patients received the same information. Patients in the gasless group 
returned to their normal activities sooner and tended to be painfree earlier than those of CO2-PP 
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group (I).  To our knowledge, no other studies  have compared gasless with CO2-PP technique in 
regard to sick leave or duration of convalescence. Koivusalo et al 14 showed that gasless 
cholecystectomy resulted in more uneventful and faster postoperative recovery than conventional 
CO2-PP. However, further studies are needed to clarify  whether this observed difference is due to 
the distended peritoneum, the absorbed CO2, or the associated acidosis.    
5.2 Systemic response 
Surgical stress response 
The clinical consequences of perioperative systemic changes – immunosuppression - are increased 
susceptibility to infective complications93 and probably increased risk of  recurrence after cancer 
surgery7. As CO2-PP may blunt the inflammatory response, it is of interest to compare the post 
traumatic immune function during CO2-PP with that of gasless laparoscopy. The effect of CO2   on 
the stress response has been investigated in eight randomized studies comparing  CO2-PP with the 
gasless technique (Table 3). Most of them have investigated the response during and after 
laparoscopic cholecystectomy, showing no change or only a slight decrease in the inflammatory 
response using  CO2-PP 35,50,51,94,95, while data on the endocrine, metabolic response are 
conflicting: two studies showed increased 52,59  two showed decreased metabolic and endocrine 
response 50,94, and one study no difference 35.  Paper III  suggests a reduced,  inflammatory reponse 
after CO2-PP compared with that of gasless laparoscopy, supporting the above-mentioned 
hypotheses. We did not expect to find any clinical difference in outcome because of the relatively 
small study group. However, our results support the hypothesis that an reduced metabolic and 
endocrine response may be followed by a more uneventful course47. It remains to be proven if 
these changes have any clinical importance regarding postoperative complications. 
Coagulation and fibrinolysis 
Fibrin formation and subsequent resolution are fundamental mechanisms involved in haemostasis  
and physiological tissue repair. Clotting involves plasma, platelets, and components in the vessel 
wall. Blood coagulation can be initiated by two pathways: the extrinsic pathway, the most 
important in vivo system  triggered by release of tissue factor from the site of injury, and the 
intrinsic pathway stimulated by contact with a negatively charged surface, now supposed to be an 
in vitro artefact96. Following initial triggering a series of serine proteases are sequentially 
activated, culminating in the formation of thrombin, the enzyme responsible for the conversion of 
soluble fibrinogen into the insoluble fibrin clot (Figure 2).  
 
  18
 
Figure 2 
Coagulation system, extrinsic pathway 
 
 
 
 
 
 
 
TISSUE 
FACTOR 
FACTOR 
VII 
 
FACTOR 
VIIa-tissue 
factor 
FACTOR
Xa 
FACTOR
IXa 
Thrombin 
FACTOR 
XI 
FACTOR 
XIa 
FACTOR 
IX 
FACTOR 
X 
Fibrin Fibrinogen
 
 
 
 
 
 
 
 
 
 
 
 
FACTOR 
X 
 
 
Prothombin   
 
 
 
 
 
 
The coagulation system is a cascade system 96 which:  
• stimulated by extern activation or autoactivation converts inert proenzymes into active 
enzymes, which by  
• limited proteolysis cleavage activates several molecules at the next step, yielding an 
exponential amplification   
• the response  may be amplified by positive feedback and by use of binding proteins to 
bring reactants together 
• the response may be inhibited by destruction of active proteins and 
• formation of inhibitor-complex formation. 
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Both genetic and environmental factors can influence the activation of coagulation and may 
predispose  to thrombosis. The CO2-PP and positioning of the patients in reverse Trendelenburg 
position may lead to venous stasis 42,97-99.  As venous stasis predisposes to venous thombosis, it 
may be speculated that CO2-PP result in increased markers of coagulation and fibrinolysis. In 
study II we investigated this hypothesis showing no differences between the the gasless and CO2-
PP groups, which suggests that the CO2-PP does not affect the coagulation and fibrinolytic system. 
Supporting our results, Dabrowiecki et al 100 demonstrated that blood samples obtained from the 
cubital vein and femoral vein during CO2-PP showed no difference in markers of coagulation and 
fibrinolysis, suggesting that venous stasis in lower extremities during laparoscopic 
cholecystectomy does not cause alterations in haemostasis. 
5.3 Haemodynamics  
Preload 
It has been suggested  that the increased, intraabdominal pressure forces blood out of the 
abdominal organs, which may result in autotransfusion and increased preload. The increased,  
central venous pressure (CVP) and pulmonary artery occlusive pressure shown in many studies 101 
10,52 may, however,  be increased secondary to the transmission of the abdominal pressure to the 
thoracic cavity. Transoesophageal echocardiography may be helpful in the monitoring of the 
ventricular filling 102. It has been shown that the left ventricular filling pressure is not associated 
with increased left ventricular diastolic area 102,103, which seriously questions the relevance of CVP 
measurements during CO2-PP . The results of the prospective studies investigating the left 
ventricular dimensions (end diastolic diameter/area)  using TOE are conflicting (Table III). 
Cunnigham et al 103, Dorsay et al.104 ,and D’Ugo 105 found no changes in the left ventricular end 
diastolic area  during CO2-PP in supine position. However, after head-up positioning  a decrease 
was registered  in two of the studies. Zuckerman et al.106 showed a significant reduction in left 
ventricular end diastolic volume placing the patients in reverse Trendelenburg position. Contrary 
to this, Gannedahl et al. 107 showed increased left ventricular volume during PP, irrespective of 
posture in cardiovascularly healthy patients. As many factors may affect the filling condition of the 
heart during surgery it is important to include a control group. To our knowledge, however, no 
control group  has been included in the studies investigating the left ventricular filling during CO2-
PP. We found a significantly increased diastolic diameter during CO2-PP compared with that of 
gasless technique, reflecting an increased venous return during CO2-PP (IV) . 
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Afterload 
In agreement with paper IV  most studies have shown increased systemic, vascular resistance. It 
has been suggested that the increased SVR and MAP may result from stimulation of hormonal 
mediators: catecholamines, renin, and vasopressin. Ogihara et al 59 showed a significantly 
increased  plasma epinephrine, norepinephrine, and dopamine  in patients undergoing laparoscopic 
ovarian resection by CO2-PP compared with that of gasless technique, whereas Koivusalo et al  
found no difference between the groups 52,66. Clonidine inhibits the release of catecholamines, and 
it has been shown that  MAP, HR, and SVR are significantly reduced, when clonidine is infused 
one hour prior to CO2-PP. This suggests an effect of the sympathetic system on the 
haemodynamics during CO2-PP 108 . A time relationship between elevated plasma vasopressin and 
increased MAP/SVR has also been found 108,109, and O’Leary et al 110 reported a fourfold increase 
in plasma renin and aldosterone concentration during LC, correlating with changes in the 
haemodynamics, which was in accordance with the findings by Koivasalo et al 52. Thus, the 
sympathetic, renin-angiotensin and vasopressin system may all be factors involved in the increase 
of afterload during CO2-PP. If absorbed CO2 per se does stimulate neurohumoral mediators, it 
might be expected that different insufflated gasses would result in different reponses, as shown in 
an animal study comparing CO2 with nitrogen PP 111. However, a human study showed no 
difference in haemodynamic parameters comparing CO2 with N2O 112.     
 
Left ventricular performance 
Left ventricular systolic performance is the ability of the left ventricle to empty. Because 
myocardial contractility is an important determinant of the left ventricle systolic performance, 
systolic performance and contractility are frequently considered to be interchangeable. However, 
they are not the same, because the systolic performance is also influenced by load. Myocardial 
contractility refers to the fundamental property of cardiac tissue, reflecting the level of activation. 
The more the amount of contraction, the more the amount of shortening. At constant preload and 
afterload increased contractility results in a greater extent and velocity of shortening. Our  study 
showed a significantly reduced FS during CO2-PP compared with that of the gasless group, 
suggesting a reduced cardiac performance as a consequence of CO2-PP. In accordance with our 
results Irwin et al.113 demonstrated reduced fractional area during CO2-PP, using a two-
dimensional echocardiographic backscatter imaging technique. However, Gannedahl et al107, did 
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not show any changes of end systolic area, nor of the fractional area during PP.  Hypercarbia and 
acidosis may occur during CO2-PP 77 and may decrease the contractility of the heart, as shown in 
an animal study 114.  
A temporal relationship between changes in pH and  FS during CO2-PP was found. However, no 
correlation was found between changes in FS and pH (n = 191, Pearson’s r = -0.073,) 
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Figure 3. Fractional shortening and pH measured preoperatively (phase 1), peroperatively 
(phases 2 and 3) and postoperatively (phase 4) in three positions. 
 This association may as well be a consequence of increased afterload. As stated in paper IV 
afterload is the load that the myocardium must bear to contract; the greater the afterload, the less 
the amount of shortening. In a simple sense MAP represents the afterload, so a relationship 
between FS and MAP may be expected. We found a low, though significant correlation between 
MAP and FS  (CO2-PP n = 268, Pearson’s r = -0,199, P < 0,001; Gasless n = 202, Pearson’ r = -
  22
0,197). 
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Figure 4. MAP measured preoperatively (phase 1), peroperatively (phases 2 and 3) and 
postoperatively (phase 4) in three positions. 
 
Cardiac output 
The integrated pumping function of the cardiovascular system ultimately results in the cardiac 
output. Four randomized studies have compared cardiac output during CO2-PP with gasless or low 
pressure laparoscopy, suggesting reduced cardiac output during CO2-PP 80,80,115 or no changes 64,65 
(Table 4). We used TOE for measurements of the CO and found no difference  in CO comparing 
gasless and CO2-PP techniques (IV). Several observational studies have investigated the effect on 
the cardiac output during laparoscopy (Table 3).  In an investigation by Joris et al 101  15 patients, 
ASA physical class I, showed a  reduction of 50% of the preoperative values during PP using 
Swan-Ganz catheter measurements. No extra volume loading was given before laparoscopy, but a 
basal infusion of 4mL/kg/h of lactated Ringer’s solution was given to compensate for 
intraoperative loss. In a similar study Hirvonen et al 116   showed a less than 20% reduction in CO 
by giving the patients extra volume loading before laparoscopy, however. Using transoesophageal 
doppler Alishahi et al117 found a similar reduction in CO during PP and head up tilt.  The question 
is, however, whether  the PP or other factors  are responsible for the decrease in CO. In a small, 
prospective, randomized study cardiac output was measured using Swan-Ganz catheter and 
thermodilution method in 15 patients assigned to open cholecystectomy, conventional 
laparoscopic cholecystectomy or gasless laparoscopic cholecystectomy80. Contrary to the results of 
our study, which showed no difference, the cardiac index was significantly reduced by 15% in 
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patients undergoing conventional laparoscopic cholecystectomy.   
 
Position 
Patient position has important effect on the haemodynamic consequences of pneumoperitoneum. 
Maximum haemodynamic changes have been observed, when PP is created with the patients in 
reverse Trendelenburg with a decline in cardiac index of 50% 101. The change from supine to 
reverse Trendelenburg positions may be accompanied by a fall in venous return, reflected by 
change in left ventricular end diastolic area103. In our study LVEDD, reflecting left ventricular 
filling ,was significantly increased immediately after CO2-PP (phase 2) compared with that of the 
gasless technique. Compared with basic values  this suggests improved left ventricular filling 
during CO2-PP. However, the LVESD was significantly increased during CO2-PP compared with 
that of the gasless technique, the result being a reduced FS during CO2-PP. This suggests a 
reduced left ventricular performance during reverse Trendelenburg position immediately after 
insufflation of CO2. The increased LVESD may be a result of increased afterload; however, the 
correlation between LVESD and MAP was low. 
 
Conclusion   
CO2-PP affects haemodynamics by increasing heart rate and  mean arterial pressure. The 
sympathetic, renin-angiotensin and vasopressin system may be involved. It remains to be 
demonstrated whether pneumoperitoneum or CO2  is responsible for the activation of the systems. 
CO2-PP increases left ventricular filling immediately after insufflation of CO2, however, left 
ventricular  performance of the heart is reduced simultaneously.  CO2-PP  has little , if any, effect 
on the CO in cardiovascularly healthy patients on the assumption that the patients are given extra 
volume. The consequence of  CO2-PP on the left heart performance is most pronounced in the 
reverse Trendelenburg position.      
5.4 Intraoperative lung function 
Lung mechanism and oxygenation 
Four randomized  studies have compared high/ low pressure  CO2-PP with gasless laparoscopy 
regarding respiratory mechanism during laparoscopic surgery. All of them showed reduced 
pulmonary compliance during CO2-PP10,59,63,67, agreeing with our results that showed reduced 
compliance during CO2-PP and further reduction, when placing patients in  Trendelenbourg 
position. The reduced compliance did not have any effect on the oxygenation. Contrary to what 
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may be expected, Odberg et al. 70 showed a 15 per cent elevation in PaO2 and a 31 per cent 
reduction in venous admixture in healthy patients during CO2-PP, suggesting reduced shunting 
during CO2-PP.  This was confirmed by Anderson et al 69 who used multiple inert gas technique, 
showing decreased pulmonary shunt and increased PaO2 during CO2-PP in cardio-pulmonarily 
healthy patients.  
 
CO2 homeostasis 
During CO2-PP the volume of absorbed CO2 is estimated to 39 ml/min 118,  matching  excess CO2 
output during CO2-PP, to 32-54 ml/min in steady state 77,119. During insufflation of CO2 , a 
significant increase in paCO2 and a decrease in pH was registered (V).  PaCO2 correlated well with 
pH (CO2-PP group n = 334, Pearson’s r = -0,852, P < 0,001) (gasless group n = 249, Pearson’s r = 
-0,883, P < 0,001) . 
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Figure 5. Correlation between PaCO2 and pH  
 
During CO2-PP carbonic dioxide output may increase by 50% 77. Even in patients with normal 
lung function CO2-PP results in increased CO2-PP and acidosis, if the increased CO2  load is not 
eliminated by increased minute ventilation, as shown in our study. With increased ventilation, 
normocarbenia can be maintained and acidosis avoided, but in patients who are cardio-pulmonarily 
compromised, this is not always possible, however 75. To adjust ventilation to the requirements of 
carbonic dioxide excretion, close monitoring of etCO2, which we found is well correlated to 
PaCO2 ,  is essential.  By using gasless technique or other gases it is possible to avoid hypercarbnia 
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and acidosis, as shown in our  study (V) and other studies as well 120,121.  . 
6. General conclusions  
The aim of this thesis was to evaluate the pathophysiological effects of CO2-PP in patients 
undergoing laparoscopy. As several individual and procedure related factors may interact, we used 
the randomized, controlled trial  to compare the clinical, systemic, and cardiopulmonary factors of 
importance for the outcome in patients undergoing LC with and without CO2-PP. The greatest 
limitation of  the present study was lack of patients with comorbidity (ASA III and IV) and 
inclusion of major abdominal surgery.  
Paper I reveals that CO2-PP and the gasless  techniques are comparable as regards 
operative time, and intraoperative and postoperative complications. The sampling time was  
standardized , making it possible to investigate the differences between CO2-PP and the gasless 
technique. During hospital stay no significant difference was registered in pain score nor in 
morphine consumption at rest or during mobilization within or between the groups (I). However, 
patients in the gasless group returned to their normal activities sooner and tended to be painfree 
earlier than those of CO2-PP group (I). CO2-PP did not affect coagulation or fibrinolytic markers 
(II), however, it was not possible in the present study to clarify if CO2-PP may be followed by a 
higher rate of thromboembolic complications than gasless or open surgery. During insufflation of 
CO2 a significant increase in paCO2 and decrease in pH is registered, whereas no changes are 
observed during gasless LC (V). It has been suggested that the cellular acidification induced by 
CO2-PP may contribute to the blunting of the inflammatory response during laparoscopic surgery. 
Paper III suggests that the postoperative inflammatory response  is reduced, whereas the metabolic 
and  endocrine responses are increased in patients undergoing CO2-PP compared with that of the 
gasless technique. The clinical  implications of this observation is difficult to evaluate, however, 
faster postoperative recovery in the gasless group may be associated with the specific effects of 
CO2-PP. Whether it is the distended peritoneum or the acidosis associated with CO2-PP which 
results in this observed difference has to be further investigated. CO2-PP affects the 
haemodynamics by increasing heart rate and  mean arterial pressure (IV). The sympathetic, renin-
angiotensin and vasopressin system may be involved. It remains to be seen whether 
pneumoperitoneum or CO2  is responsible for the activation of the systems. CO2-PP increases left 
ventricular filling immediately after insufflation of CO2, however, left ventricular  performance of 
the heart is reduced simultaneously (IV). The simultaneous respiratory acidosis after insufflation 
of CO2 could be an important factor determining part of the decreasing heart performance. 
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However, no correlation between heart performance measured by fractional shortening and mean 
arterial pressure was found. The observed haemodynamic effects of CO2-PP did not have any 
consequenses on the cardiac output  (IV). However, our study  was limited to cardiopulmonarily 
healthy patients only. Clinical studies on ASA III and IV patients have shown serious 
haemodynamic changes during CO2-PP. 
Table 5 summarizes the overall effects of CO2-PP shown in papers I-V: 
Study Parameter  Pre. 
operative 
Induction Operation 
 5 minutes 
Operation 
30 minutes 
Post.op.  Post.op 
24 h 
Conval
escence 
I Wound pain     → → ↑ 
Clinical Visceral pain     → → ↑ 
Outcome 
 
Convalescen
ce 
      ↑ 
 II  F1 + 2 → → → → →   
Coagulation Soluble fibrin → → → → →   
Fibrinolysis d-Dimer → →  → →   
III  Cortisol → → ↑ ↑ → →  
Systemic Insulin → → → ↑ → →  
response Glucose → → → → → →  
 CRP → → → → → ↓  
IV  LVEDD  → ↑ ↑ ↑   
Heart LVESD  → ↑ ↑ ↑   
haemodyna
mics 
FS  → → ↓ →   
 CO  → → → →   
 HR → → ↑ ↑ →   
 MAP → → ↑ ↑ →   
V Compliance  → ↓ ↓ →   
Lung PaCO2  → → ↑ ↑ → (↑*)   
function PaO2 → → → → →   
 pH → → ↓ ↓ → (↓*)   
 etCO2   → ↑ ↑ → (↑*)   
 
Tabel 5. Overall effects and outcome in patients undergoing CO2-PP or gasless LC. 
↑: Significantly increased effect of  CO2-PP compared with that of gasless technique. 
→:  No difference between CO2-PP and   gasless technique.  
↓: Significantly reduced effect of CO2-PP compared with that of gasless technique . 
* Significant difference between parameters compared with that of  induction phase.  
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7. Future research 
7.1 Inflammatory and immune response. 
The clinical outcome after laparoscopic surgery concerning sepsis, pneumonia, urinary tract 
infections, local tumour growth and metastases are important issues which are poorly evaluated, 
however. There is evidence that surgical stress impairs immunity and that this is more intense 
within open than  laparoscopic surgery (Table 2). Immunity plays a significant role in tumour  
progression and metastatic  spread {Bouvy, 1997 1167 /id. A large-scale, randomized, controlled 
trial suggests that laparoscopically assisted colectomy is more effective than open colectomy for 
the treatment of colon cancer in terms of tumour recurrence and cancer-related survival 7. 
However, use of CO2-PP has been intensively debated regarding port-site recurrence and 
intraperitoneal tumour growth 91,122. Large-scale, multicentre, clinical studies are currently being 
performed in Europe and the United States, the oncological results of which will be available in a 
few years.  
• Further experimental studies are needed concerning mobilization and spread of neoplastic 
cells in relation to choice of 
o Surgical technique 
o Insufflated gas 
o Pressure 
o Gasless technique 
in  addition to 
• clinical studies comparing open fast trac surgery with laparoscopic technique concerning 
long time cancer related survival. 
7.2 Haemodynamics 
• Heart performance. The haemodynamic changes in high risk ASA III and IV patients 
need further investigations such as 
o Evaluation of methods for the monitoring of cardiac function 
 TOE 
 Pulmonary arterial catheter  
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o Additional, randomized, controlled studies are needed to evaluate the effect of 
different interventions on the haemodynamic parameters 
 Pharmacotherapy 
 Gasless technique 
 Inert gas 
 
• Circulation. In patients with cardiovascular disease or organ disorders  prolonged CO2-PP 
may result in reduced perfusion and organ function. Further experimental and clinical 
studies are needed regarding     
                                            Splanchnic perfusion. 
  measured by microdialysis technique  
o Renal perfusion  
 Measured by microdialysis  technique 
o Hepatic perfusion.  
o CNS  
 7.3 Lung Function 
• Patients with pulmonary disease may have retention of CO2 postoperatively. However,  
little is known about the clinical, postoperative, pulmonary complications and the CO2 – 
homeostasis in patients with obstructive pulmonary disease. Further studies are needed 
regarding: 
o Per- and postoperative excretion of CO2 in patients with pulmonary disease. 
o Postoperative clinical, pulmonary complications in patients with pulmonary 
disease.  
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8. English summary 
The number of laparoscopic procedures is still rising and within the field of gastro-intestinal 
surgery, urology, and gynaecology the laparoscopic procedure has now become the gold standard. 
The prerequisite for laparoscopic surgery is a working cavity. Positive pressure carbonic dioxide 
pneumoperitoneum (CO2-PP) and positional changes of the patients are the general methods of 
exposing the intraperitoneal organs. Carbonic dioxide (CO2) is the preferred gas, because it is 
inexpensive, highly soluble, and chemically stable. In addition, it suppresses combustion and is a 
normal product of human metabolism. There is, however, some concern in regard to CO2-PP, 
which may affect the cardiovascular and pulmonary functions. CO2 is absorbed from the peritoneal 
cavity into the circulation, where it may result in hypercarbia, acid-base disturbances, and may 
affect the systemic response and the plasma cascade systems.  As the laparoscopic procedures are 
also offered to patients with co-morbidity, it is mandatory to be aware of the specific, 
intraoperative, pathophysiological effects that are related to laparoscopic surgery, when using 
positive  pressure CO2-PP and to evaluate alternative, minimally invasive methods.  
 Based on a randomized design comparing conventional with gasless laparoscopy 
the effects of  CO2-PP are investigated in regard to: 
• outcome, pain, convalescence,  
• coagulation and fibrinolysis 
• surgical stress response 
• perioperative haemodynamics and heart performance 
• perioperative respiratory function 
 
The studies  revealed that: 
• convalescence is significantly prolonged in patients undergoing surgery with CO2-PP 
compared with gasless technique. However, no difference is registered in postoperative 
pain or hospital stay 
• coagulation and fibrinolysis is not  enhanced by CO2-PP 
• endocrine and metabolic response may be activated and the inflammatory response 
blunted by CO2-PP 
• mean arterial pressure and heart rate is increased during CO2-PP 
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• preload and afterload is increased, heart performance decreased, but cardiac output not 
affected during CO2-PP 
• the haemodynamic effects are most pronounced in the reverse Trendelenburg position 
• static lung compliance is reduced, hypercarbia and acidosis follows CO2-PP 
• postoperative hypercarbia and acidosis may be due to hypoventilation rather than CO2 
accumulation after CO2-PP laparoscopy.  
Further studies are needed to evaluate the long time effects on cancer related survival in patients 
undergoing laparoscopic surgery compared with that of open fast trac surgery and different 
laparoscopic techniques. In addition, the evidence of the effect of CO2-PP on high risk cardio-
pulmonary patients are insufficient. 
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9. Danish summary – dansk resumé 
Laparoskopisk kirurgi har vundet stigende udbredelse inden for mave-tarm kirurgi, urologi og 
gynækologi pga. det reducerede kirurgiske traume, som i forhold til åben kirurgi medfører kortere 
indlæggelsestid  og rekonvalescens. Forudsætningen for at udføre kikkert kirurgi i bughulen er 
etablering af en arbejdskavitet. Traditionelt anvendes  kuldioxid (CO2), som er ufarligt, hurtigt 
opløseligt, ikke-brændbart og billigt, ligesom det normalt ikke danner luftbobler ved optagelse i 
blodbanen.  Overtryks CO2-pneumoperitoneum har imidlertid nogle virkninger, som i kombination 
med de til tider ekstreme lejeændringer kan have  en række uheldige konsekvenser for forskellige 
organsystemer. Da laparoskopi i stigende omfang også tilbydes patienter med konkurrerende 
lidelser, er det vigtigt at have viden om bivirkningerne af CO2 –pneumoperitoneum. 
Baseret på et randomiseret design sammenlignes konventionel  med gasløs laparoskopi mhp. at 
analysere virkningen af CO2 –pneumoperitoneum på: 
• klinisk forløb, postoperative smerter og rekonvalescens 
• koagulations- og fibrinolysemarkører 
•  kirurgisk stress respons 
•  perifer kredsløb og  perioperativ hjertefunktion 
•  perioperativ lungefunktion og blodgasser 
 
Undersøgelserne viser, at CO2 –pneumoperitoneum 
           medfører længere rekonvalscens sammenlignet med gasløs teknik, men øger ikke de           
postoperative smerter eller indlæggelsestiden 
• påvirker ikke koagulations- og fibrinolysemarkørerne 
• påvirker det kirurgiske respons ved at øge det endokrine og metabolske respons og 
hæmme det inflammatoriske  
• øger pulsfrekvensen og blodtrykket  
• øger hjertets preload og afterload samt hjertefunktionen, dog uden at påvirke cardiac 
output 
• påvirkningen af hjertefunktionen er mest udtalt i anti Trendelenburg 
• øger lungernes statiske compliance og medfører hyperkapni samt respiratorisk acidose 
uden at påvirke iltningen af det arterielle blod. 
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Der mangler viden om, hvilken langsigtet effekt, laparoskopi har på den cancer relaterede 
overlevelse. Ligeledes mangler der viden om de kort- og langsigtede, patofysiologiske virkninger 
af CO2 –pneumoperitoneum blandt patienter med alvorlige hjerte-lunge problemer. 
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10. Tables  
Table 1. Controlled, clinical trials. 
 
Operation 
 
 
author/year 
References 
 
 
Intervention 
 
Number 
 
Outcome 
Perioperative 
 
Outcome  
Follow-up 
 
 
Recommendation 
 Barkun, 1992 15 
Laparoscopic vs. 
mini  
 
70 ↓Hospital stay  
↓Convalscense 
 
 
LC preferred 
 Super, 1996 24 
Laparoscopic  vs 
mini  
 
100 ↓Pain →Hospital stay 
→Convalscense 
 
Comparable 
Procedures 
 Majeed, 1996 25 Laparoscopic vs mini 200 
↑Operative time 
→Hospital stay 
→convalescense 
 
LC no significant 
advantages 
Cholecystectomy Kunnz, 1992 26 
Laparoscopic vs 
mini 
 
77 
→Operative time  
↓Postop pain 
↓Hospital stay 
   LC preferred
 McGinn, 199512 Laparoscopic vs mini 310 
→Hospital stay 
↓Pain 
 
↓Convalscense  
 
LC preferred 
 
 McMahon,1995 11 Laparoscopic vs. mini 299  
1 year follow- up: 
90% symptomatic 
benefit both groups 
No difference long 
time follow up 
 
 Hendolin, 2000 9 
Laparoscopic vs 
Open  
 
49 
↓Hospital stay 
↓Pain  
 
↓Sick leave  
 
LC preferred 
 
  
Table 1 cont.       
 
Operation 
 
References 
author/year 
 
Intervention 
 
Number 
 
Outcome 
Perioperative 
 
Outcome  
Follow-up 
 
 
Recommendation 
 Koivusalo, 1996 14 
Gasless 
Laparoscopic vs 
Conventional 
Laparoscopic 
26 
↓Nausea 
↓Vomiting 
↓Shoulder pain 
↓Recovery 
   Gasless preferred
cholecystectomy Lindgren, 1995 10 
Abd wall lift vs 
Conventional 
laparoscopic 
25 
↓Nausea 
↓Vomiting 
↓Shoulder pain 
 
 
Abd wall lift 
preferred 
 
 
 Sarli, 2000 
13 
 
Low vs high 
pressure 90 
↓Shoulder pain 
  
Low pressure 
preferred 
 Vezakis, 1999 
17 
 
Gasless vs Low 
pressure 
Laparoscopic   
36 
↓Exposure 
→Pain 
↑Operative time 
 
 Gasless value in high risk patients 
Inguinal hernia Cochrane, 2003 Review 6 
Laparoscopic mesh 
vs open mesh 7161 
↑Operative time 
↓haematoma 
↑Seroma 
↓infection 
→hospital stay 
↓Normal activity 
↓Persistent pain 
↓numbness 
→recurrence 
 No  
Ventral hernia Carbajo 1999 18 Laparoscopic mesh vs open mesh 60 
↓Operative time 
↓Hospital stay 
 
↓Recurrence rate No 
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Table 1 cont.       
 
Operation 
 
References 
author/year 
 
Intervention 
 
Number 
 
Outcome 
Perioperative 
 
Outcome  
Follow-up 
 
 
Recommendation 
Appendicitis 
 
Cochrane Review 
3 
Laparoscopic vs 
open 39 studies 
↓Wound infection 
↑Operative time 
↓Pain 
↓Hospital stay 
↓Negative app. 
↓Convalscence  Laparoscopy
 Nilsson 2000 
Laparoscopic vs 
open 
fundoplicatio 
19,21 
 
60 
↑Operative time 
↓Pain 
↓Hospital stay 
 
→Convalscence 
→well being 
 
 
 
Gastro-
oesophageal 
reflux 
Bais 2000 22 
 
Laparoscopic vs 
open 
fundoplication 
42  
Cured 
→oesophagitis 
→quality of life 
 
 
 
Laostarnen 2001 
20 
 
Laparoscopic vs 
open 
fundoplication 
28    
      Laine 1997 
Laparoscopic vs 
open 
fundoplication 
23 110
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Table 1 cont.       
 
Operation 
 
References 
author/year 
 
Intervention 
 
Number 
 
Outcome 
Perioperative 
 
Outcome  
Follow-up 
 
 
Recommendation 
 Lacy 2002 7 
Laparoscopy vs 
open 
 
 
219 
 
Recovery faster 
Bowel function faster  
Oral intake faster 
↓Morbidity 
Periop →mortality 
↓Hospital stay 
5-year survival↑ 
Laparoscopy 
 
 
 
Delgado 2000 
{Delgado, 2000 716 
/id} 
Laparoscopy vs 
open 
 
 
255 
Operative time 
→Morbidity< 70 years 
↓Morbidity  > 70 years 
 
 
> 70 years 
laparoscopy 
 
Colo-rectal 
neoplasms Schwenk 1998  
123 
Laparoscopy vs 
open 
 
 
60 Bowel function faster Oral feeding faster  
short term 
laparoscopy 
Long term ? 
 
 Milsom 1998 29 
Laparoscopy vs 
open 
 
 
109 
↓Pain 
Bowel function faster 
 
 
Short term 
laparoscopy 
Long term ? 
 
 Stage 1997 
27 
 
Laparoscopy vs 
open 
 
 
29 ↓Hospital stay ↓Pain   No
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Table 1 cont.       
 
Operation 
 
References 
author/year 
 
Intervention 
 
Number 
 
Outcome 
Perioperative 
 
Outcome  
Follow-up 
 
 
Recommendation 
 De Wit 1999 32 
Laparoscopic adj. 
Silicone banding vs 
open 
 
 
50 
↓Operative time 
↓Hospital stay 
→Complications 
 
↓Readmission 
→Weight loss 
 
Laparoscopy 
 
Obesity Westling 2001 31 
Laparoscopic gastric 
bypass vs open 
 
51 
↓Pain 
↓Hospital stay 
↑Reoperation  
↑Conversion  
 
→Weight loss 
 
No 
 
 Nguyen 2001 30 Laparoscopic gastric bypass vs open 150 
↑Operative time 
↓Hospital stay 
↓Wound infecti  
↓Incisional hernia 
Anastomosis 
↑stricture 
→Weight loss 
↑Quality of life 
 
Laparoscopy 
Splenectomy No randomized 
trials 
     
Staging   No randomized 
trials 
     
Inflammatory 
Bowel Disease 
 
Milson 2001 16 
 
Laparoscopic vs 
open ileocecal 
Crohn 
 
60 
→Pain 
Bowel function ↑faster 
↓Hospital stay  
Minor ↓complications  
Major →complications 
 
→Clinical 
recurrence 
 
Laparoscopy 
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Table 2. Endocrine, metabolic, and inflammatory reponse. 
Effects of laparoscopic surgery on intraoperative and postoperative endocrine, metabolic, and immune responses 
 (clinical studies). → : no difference between laparoscopic vs open/gasless surgery; ↓ : Reduced response in  
laparoscopic vs. open/gasless surgery; ↑increased response in laparoscopic vs. open/gasless surgery.  
Lap.: laparoscopic; chol.: cholecystectomy; IL: Interleucin; CRP: C-reactive protein;  
ACTH: adrenocorticotrophic hormone; u: urine 
 
 
Reference Year Operation Intervention Duration Parameter 
 
Comments 
 
Anone et al 53 1998 Lap . chol. 
General 
anaesthesia vs 
general + 
fentanyl vs 
general + 
epidural 
perioperative 
↑ cortisol all groups 
↑Cathecholamines  
group I 
Randomized 
N=52 
Bello et al 124 1998 Cholecystectomy.   Laparoscopic vs. open 7 days 
→IL-1, IL-6,  →IL-
10, →Prolactin, 
→Cortisol,  →Growth 
H 
Non randomized 
N=40 
Engin et al 58   1998 Cholecystectomy Laparoscopic vs. open perioperative ↓glucagon, ↓Insulin 
Randomized 
N=32 
Koivusalo et al 52 1998 Cholecystectomy   CO2-PP vs. gasless perioperative ↑cathecholamines 
Randomized 
N=26 
 
Table 2 cont.       
Reference Year Operation Intervention Duration Parameter  
  
 
39 
Comments 
 
Nanashima et al 
95 1998 Cholecystectomy   
CO2-PP  vs. 
gasless 2 days → IL-6 
Non 
randomized 
N=27 
Ninomiya et al 51 1998 Cholecystectomy   CO2-PP  vs. gasless  
→IL-6, 
→CRP  
→neutrophil 
elastase 
Non 
randomized 
N=20 
Holub et al 125 1999   Hysterectomy   Laparoscopic vs. open ? ↓CRP 
Non 
randomized 
N=32 
Ogihara et al 59  1999 Lap ovarian resection     
CO2-PP vs. 
gasless perioperative 
↑cathecolamines 
↑dopamin  
↑Anti diuretic hor 
→cortisol 
Randomized 
N=12 
Schulze et al 35 1999 Lap. Colon resection  CO2-PP vs gasless 10 days 
→ IL-6 
→ CRP 
Randomized 
N=17 
Blanc-Louvry et 
al 56 2000   Cholecystectomy
Laparoscopic 
vs. open 1 day 
↓ACTH  
↓urine cortisol 
↓urine catechol 
Randomized 
N=41 
 Hendolin et al 9   2000 Cholecystectomy Laparoscopic vs. open ? 
→catecholamines 
→cortisol,  
→glucose  
Randomized 
N=49 
Ishizuka et al 94 2000 Lap.chol    CO2-PP vs gasless 1 day 
↓catecholamines 
↓IL-6 
↑cortisol 
Non 
randomized 
N=31 
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Table 2 cont.       
Reference Year Operation Intervention Duration Parameter 
 
Comments 
 
Uzunkoy et al 57   2000 Herniotomy Laparoscopic vs. open 2 days 
↓CRP 
→Cortisol 
→Glucose 
Randomized 
N=50 
Rorarius et al 126   2000 Hysterectomy Laparoscopic vs. vaginal ? 
→CRP 
→ACTH →Cortisol 
→Glucose 
Non 
randomized 
N=20 
Nguyen et al 54 2002 Gastric bypass  Laparoscopic vs. open 3 days 
→Insulin 
→Glucose 
→Catecholamines 
→Dopamine 
↓ACTH  
↓Cortisol  
↓CRP  
↓IL-6  
→Nitrogen balance 
Randomized 
N=48 
Solomon et al 55 2002  Rectopexy vs   Laparoscopic vs. open ? 
↓Urine-
↓catecholamine  
IL-6 ↓Cortisol 
↓CRP  
Randomized 
N=40 
Uen et al 50  2002 Cholecystectomy CO2-PP vs gasless 2 days 
↓u-Cortisol  
↓CRP  
↓IL-6 
Randomized 
N=95 
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Table 2 cont.       
Reference Year Operation Intervention Duration Parameter 
 
Comments 
 
Larsen et al127   2002 Cholecystectomy CO2-PP vs gasless 1 day 
↑Cortisol 
↑Insulin 
→Glucose 
↓CRP  
Randomized 
N=50 
Hildebrant et 
al 128 2003 
 Colon resection   
for inflammatory 
bowel disease 
Laparoscopic 
vs. open ? 
IL-6 IL-10 
CRP 
Granulocyte 
elastase 
Non 
randomized 
N=42 
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Table 3. Haemodynamics, clinical trials. 
 
Haemodynam
ic parameters 
Decrease  Unaltered  Increase  
 Authors, year Ref.   Ref. Authors, years Ref. 
Heart Rate   
Joris, 1993  
Myre, 1997  
Joris, 1998  
Elliott, 1998 
Myre, 1998 
Zuckerman,2001, 
Irwin, 2001 Galizia, 
2001 
Uen, 2002  
 
50,80,101,102,106,108,11
3,129,130 
 
Andersson,1999 
Hirvonen, 2000 
 
116,131 
 
Mean Arterial 
Pressure 
    Uen, 2002 50 
Joris, 1993,  
Koivusalo, 1997, 
 Myre 1998, 1998
52,63,101,108,113,129,131 
 
Systemic 
Vascular 
Resistance 
   Dhoster, 1996 132 
Critchley, 1993  
Joris 1993, 1998 
Walder, 1997  
Zollinger, 1997  
Volpino, 1998  
Hirvonen, 2000 
101,108,109,116,133-135 
 
Cardiac output 
Westerband, 1992 
Safran, 1993  
Joris, 1998 
76,108,136    Andersson, 1999 131 Dhoster, 1996 132 
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Table 3 cont.       
Haemodynam
ic parameters 
Decrease  Unaltered  Increase  
 Authors, year Ref.   Ref. Authors, years Ref. 
 
Cardiac index 
Dorsay, 1995  
Koksoy, 1995  
Elliot, 1998  
McLaughlin, 1995 
Walder, 1997 
 Wallace, 1997 
Elliot, 1998  
Galizia, 2001  
65,80,104,109,130,134,1
37,138 
Critchley, 1993 
Walder, 1997 
Odeberg, 1994 
Zuckerman, 2001  
102,106,109,135,139 
 Hashimoto 
1993, 
Dhoster 1996  
72,132 
 
End diastolic 
diameter 
 
      D’Ugo, 2000 105
End systolic 
diameter       D’Ugo, 2000 
105
Fractional area Irwin, 2001 113     
End diastolic 
area 
 
Cunnigham, 1993 103 Couture, 1997  140,141 Gannedahl 1996 
107 
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Table 4 Haemodynamics, randomized, controlled trials 
 .Hemodynamics. Randomized, controlled trials. ↑: higher; →: no difference; ↓: reduced 
 
 
Author 
 
 
Reference 
 
Operation 
 
Intervention 
 
Parameter 
 
Comments 
Lindgren et al 
1995 
10   Lap. chol. CO2-PP vs. gasless 
↑MAP,  
→ HR  
↑CVP 
Randomized 
N=25, Human 
Koivusalo et al 
1996 
66   Lap. chol. CO2-PP vs. gasless 
↑p-renin 
 → noradrenalin 
Randomized 
N=24 
Koivusalo et al 
1997 
63  Lap.chol. CO2-PP vs. gasless 
↑MAP,  
→HR 
Randomized 
N=29 
Casati 1997 67 Gynaecological laparoscopy CO2-PP vs.  gasless
↑ diastolic pressure → 
HR 
Randomized 
N=20 
Wallace 1997 65  Lap.chol
CO2-PP high (15 
mmHg) vs. CO2-PP 
low (7.5mmHg) 
→HR  
→CI  
Randomized 
N=20 
Miejer 1997 64   Lap. Chol.
CO2-PP vs wall 
traction and low 
CO2-PP 
→Diastolic press. 
→Systolic press.  
→HR  
→CO 
Randomized 
N=18 
Koivusalo 1998 52  Lap.chol. CO2-PP vs. gasless 
↑MAP  
↑HR →norepinephrine 
→epinephrine  
Randomized 
N=13 
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Table 4 cont.      
 
Author 
 
 
Reference 
 
Operation 
 
Intervention 
 
Parameter 
 
Comments 
Ogihara et al 
1999  
52,59 Laparoscopic ovarian resection  CO2-PP vs. gasless 
↑MAP →HR 
↑Dopamine 
↑Epinephrine 
↑Norepinephrine 
Randomized 
N=12 
Schulze et al 
1999 
35 Laparoscopic colon resection CO2-PP  vs gasless 
→ MAP 
↑ HR  
↑ CVP 
Randomized 
N=17 
Dexter et al 1999 115   Lap. chol.
CO2-PP high (15 
mmHg) vs. CO2-PP 
low (7mmHg) 
↑MAP  
↑HR  
↓SV  
↓CO 
Randomized 
N=20 
Galizia et al 2001 52,80  Lap.chol. CO2-PP vs. Gasless vs open 
↑MAP 
→HR  
↑SVR 
↓CO 
↓CI 
Randomized 
N=15 
Uen et al 2002 50,52  Lap.chol. CO2-PP vs. gasless 
→MAP 
→HR 
Randomized 
N=95 
Tsereteli  et al 
2002 
112 
Elective 
laparoscopic 
surgery 
CO2-PP vs. N2O 
→MAP 
→HR 
Randomized 
N=103 
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